Search research articles
Contact Us
Filters
Showing results (1-10 of 442) with videos related to
Page
of 45
Sort By:
European Heart Journal
|
December 11, 2019
Sudden death in heart failure: do we understand what we observe?
Morten Schou, Lars Køber
JACC. Cardiooncology
|
June 19, 2025
Cardiovascular Care After Cancer: Is It Time to Emphasize Event-Free Survival Rather Than Cardiovascular Risk?
Nina Nouhravesh, Morten Schou
Evidence-Based Mental Health
|
September 27, 2017
NMDA receptor antibodies are found in a small subgroup of patients with first-episode psychosis, but their clinical relevance is unknown
Morten Schou, Sverre Georg Saether
BMC Psychiatry
|
May 5, 2017
What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review
Sverre Georg Sæther, Morten Schou, Daniel Kondziella
Journal of the American College of Cardiology
|
May 10, 2023
SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease: Jigsaw Falling Into Place
Søren L Kristensen, Jesper Jensen, Morten Schou
Innate Immunity
|
January 20, 2010
Identifying the functional part of heparin-binding protein (HBP) as a monocyte stimulator and the novel role of monocytes as HBP producers
Morten Schou, René Djurup, Kjeld Norris, et al.
European Heart Journal
|
January 16, 2007
Long-term clinical variation of NT-proBNP in stable chronic heart failure patients
Morten Schou, Finn Gustafsson, Andreas Kjaer, et al.
European Heart Journal
|
February 21, 2021
Immune check point inhibitors are associated with a spectrum of cardiac events in patients with cancer
Maria D'Souza, Inge Marie Svane, Gunnar Gislason, et al.
The Lancet. Diabetes & Endocrinology
|
April 17, 2021
Fluid volume regulation in patients with heart failure - Authors' reply
Jesper Jensen, Massar Omar, Jacob Eifer Møller, et al.
JACC. Heart Failure
|
June 2, 2018
Reply: Aspirin and Prognosis in Heart Failure: A Question of Power
Christian Madelaire, Gunnar Gislason, Christian Torp-Pedersen, et al.
Page
of 45
Search research articles
Search
Showing results (1-10 of 442) with videos related to
Sort By:
Page
of 45
European Heart Journal
|
December 11, 2019
Sudden death in heart failure: do we understand what we observe?
Morten Schou, Lars Køber
JACC. Cardiooncology
|
June 19, 2025
Cardiovascular Care After Cancer: Is It Time to Emphasize Event-Free Survival Rather Than Cardiovascular Risk?
Nina Nouhravesh, Morten Schou
Evidence-Based Mental Health
|
September 27, 2017
NMDA receptor antibodies are found in a small subgroup of patients with first-episode psychosis, but their clinical relevance is unknown
Morten Schou, Sverre Georg Saether
BMC Psychiatry
|
May 5, 2017
What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review
Sverre Georg Sæther, Morten Schou, Daniel Kondziella
Journal of the American College of Cardiology
|
May 10, 2023
SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease: Jigsaw Falling Into Place
Søren L Kristensen, Jesper Jensen, Morten Schou
Innate Immunity
|
January 20, 2010
Identifying the functional part of heparin-binding protein (HBP) as a monocyte stimulator and the novel role of monocytes as HBP producers
Morten Schou, René Djurup, Kjeld Norris, et al.
European Heart Journal
|
January 16, 2007
Long-term clinical variation of NT-proBNP in stable chronic heart failure patients
Morten Schou, Finn Gustafsson, Andreas Kjaer, et al.
European Heart Journal
|
February 21, 2021
Immune check point inhibitors are associated with a spectrum of cardiac events in patients with cancer
Maria D'Souza, Inge Marie Svane, Gunnar Gislason, et al.
The Lancet. Diabetes & Endocrinology
|
April 17, 2021
Fluid volume regulation in patients with heart failure - Authors' reply
Jesper Jensen, Massar Omar, Jacob Eifer Møller, et al.
JACC. Heart Failure
|
June 2, 2018
Reply: Aspirin and Prognosis in Heart Failure: A Question of Power
Christian Madelaire, Gunnar Gislason, Christian Torp-Pedersen, et al.
Page
of 45